NCT05996939

Brief Summary

Lymphedema is an external manifestation of lymphatic system insufficiency and deranged lymph transport. It is defined as accumulation in the extracellular space of protein-rich fluid, due to a mechanical failure of the lymphatic system. Lymphedema directly affects the quality of life of the patient, not only in the physical aspect, but also in the psychological, sexual and social aspects. Muscle and joint pumps are important external mechanisms of lymphatic and venous fluid return improvement. The unstable shoes demands, especially during standing, increased muscle activity in the lower extremities. A clinical trial was carried out comparing both kinds of footwear, the objective being to evaluate possible differences in the evolution of lymphedema. Unstable shoes (MBT®) were compared with conventional sports shoes. During a clinical trial lasting eight weeks, we assessed quality of life, limb volume, and symptoms derived from lymphedema. The results suggested that the use of unstable shoes is recommendable for walking and for long periods of standing, since it decreases leg cramping and paraesthesia of affected limbs.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2013

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2016

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2017

Completed
6.1 years until next milestone

First Submitted

Initial submission to the registry

July 28, 2023

Completed
21 days until next milestone

First Posted

Study publicly available on registry

August 18, 2023

Completed
Last Updated

August 18, 2023

Status Verified

August 1, 2023

Enrollment Period

2.7 years

First QC Date

July 28, 2023

Last Update Submit

August 10, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Volume of the lower limb

    Volume of the lower limb

    8 weeks

Secondary Outcomes (2)

  • Circumference measure of the foot

    8 weeks

  • Changes in lymphedema symptoms

    8 weeks

Study Arms (2)

Unstable shoes

EXPERIMENTAL

Use of unstable shoes for 8 weeks

Other: To compare the efficacy of unstable shoes with that of conventional sports shoes in people with lower-limb primary and secondary lymphedema.

Usual sports footwear

NO INTERVENTION

Use of conventional shoes for 8 weeks

Interventions

Unstable shoes were compared with conventional sports shoes, the objective being to evaluate possible differences in the evolution of lymphedema. During a clinical trial lasting eight weeks, we assessed quality of life, limb volume, and symptoms derived from lymphedema.

Unstable shoes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects affected with lower limb lymphedema -primary, secondary, unilateral or bilateral-, -Daily use of a compression stocking

You may not qualify if:

  • Subjects with acute infection of the affected limb
  • that did not had any treatment for lymphedema one year prior to the study,
  • Weight \<40kg,
  • shoe size \<EU35 or \>EU47
  • that have previously used unstable shoes
  • vestibular alterations, vertigo, hypoacusis
  • visual compromise that affects balanc

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

July 28, 2023

First Posted

August 18, 2023

Study Start

November 1, 2013

Primary Completion

June 30, 2016

Study Completion

June 30, 2017

Last Updated

August 18, 2023

Record last verified: 2023-08